MTNB Nilai Total Aset Perusahaan Matinas BioPharma Holdings Inc.

The asset value for Matinas BioPharma (MTNB) tracked on the chart is 7.42, based on the use of unique lipid crystals for oral drug delivery via B2B contracts. Matinas BioPharma is implementing automated software and robotics to analyze clinical data sets for oligonucleotides. The development strategy relies on the monetization of patents for increasing drug bioavailability through a royalty system.

MTNB (Matinas BioPharma Holdings) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 29.10.2026

Rincian analitis lan laporan data perusahaan matinasbiopharma.com (MTNB)

- rega saham lan konsensus proyeksi valuasi:

Bagan rega Matinas BioPharma Holdings|MTNB - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Matinas BioPharma|MTNB - Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi Saham Matinas BioPharma|MTNB - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku matinasbiopharma.com|MTNB - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Matinas BioPharma|MTNB - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Matinas BioPharma Holdings|MTNB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Matinas BioPharma|MTNB - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Matinas BioPharma

Pambiji fundamental:Matinas BioPharma

Produk sing diprodhuksi Matinas BioPharma Holdings, Inc.

Given the necessity of maintaining strategic reserves of lipid nanocrystals to ensure supply stability, the trajectory of total assets (via ROA) reflects the actual scale of Matinas BioPharma resources, reverse-calculated as the sum of liabilities and equity through return on assets, allowing the investor to assess the business's actual material base and its resilience to macroeconomic shocks without the risk of excessive debt load.

Pesaing wigati